{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T16:12:12Z","timestamp":1785946332353,"version":"3.56.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Dermatologic Clinics"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.det.2024.02.002","type":"journal-article","created":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T04:09:34Z","timestamp":1710475774000},"page":"399-404","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Phototherapy for Psoriasis in the Age of Biologics"],"prefix":"10.1016","volume":"42","author":[{"given":"Aaron Gabriel W.","family":"Sandoval","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjun","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Buzney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.det.2024.02.002_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0051752","article-title":"Involvement of IL-9 in Th17-associated inflammation and angiogenesis of psoriasis","volume":"8","author":"Singh","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.det.2024.02.002_bib2","doi-asserted-by":"crossref","DOI":"10.1172\/JCI1476","article-title":"IL-10 is a key cytokine in psoriasis: Proof of principle by IL-10 therapy: A new therapeutic approach","volume":"101","author":"Asadullah","year":"1998","journal-title":"J\u00a0Clin Invest"},{"issue":"1","key":"10.1016\/j.det.2024.02.002_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.det.2019.08.004","article-title":"How it works: the immunology underlying phototherapy","volume":"38","author":"Yu","year":"2020","journal-title":"Dermatol Clin"},{"issue":"2","key":"10.1016\/j.det.2024.02.002_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.jphotobiol.2005.08.011","article-title":"Narrow-band UVB induces apoptosis in human keratinocytes","volume":"82","author":"Aufiero","year":"2006","journal-title":"J\u00a0Photochem Photobiol, B"},{"issue":"1","key":"10.1016\/j.det.2024.02.002_bib5","article-title":"Phototherapy in psoriasis: A review of mechanisms of action","volume":"17","author":"Wong","year":"2013","journal-title":"J\u00a0Cutan Med Surg"},{"issue":"5","key":"10.1016\/j.det.2024.02.002_bib6","doi-asserted-by":"crossref","DOI":"10.1038\/sj.cdd.4401007","article-title":"p53 and Fas ligand are required for psoralen and UVA-inducedapoptosis in mouse epidermal cells","volume":"9","author":"Santamaria","year":"2002","journal-title":"Cell Death Differ"},{"issue":"3","key":"10.1016\/j.det.2024.02.002_bib7","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1001\/jamadermatol.2019.4029","article-title":"Comparison of biologics and oral treatments for plaque psoriasis: a meta-analysis","volume":"156","author":"Armstrong","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"SUPPL. 3","key":"10.1016\/j.det.2024.02.002_bib8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1468-3083.2012.04519.x","article-title":"Efficacy of Psoralen UV-A therapy vs. Narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review","volume":"26","author":"Archier","year":"2012","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"11","key":"10.1016\/j.det.2024.02.002_bib9","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1111\/jdv.17519","article-title":"The use of psoriasis biomarkers, including trajectory of clinical response, to predict clearance and remission duration to UVB phototherapy","volume":"35","author":"Watson","year":"2021","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.det.2024.02.002_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2019.05.080","article-title":"Patient-reported outcomes of adalimumab, phototherapy, and placebo in the Vascular Inflammation in Psoriasis Trial: A randomized controlled study","author":"Noe","year":"2019","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"521","key":"10.1016\/j.det.2024.02.002_bib11","first-page":"1","article-title":"Phototherapy with narrow-band ultraviolet b in adult psoriasis: a study in clinical practice","volume":"11","author":"Fern\u00e1ndez-Guarino","year":"2020","journal-title":"J\u00a0Clin Exp Dermatol Res"},{"key":"10.1016\/j.det.2024.02.002_bib12","article-title":"Onset of action of biologics in patients with moderate-to-severe psoriasis","author":"Papp","year":"2018","journal-title":"J\u00a0Drugs Dermatol JDD"},{"issue":"4","key":"10.1016\/j.det.2024.02.002_bib13","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.jaad.2018.11.057","article-title":"Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics","volume":"80","author":"Menter","year":"2019","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.det.2024.02.002_bib14","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jaad.2017.01.037","article-title":"Risk for hepatitis B and C virus reactivation in patients with psoriasis on biologic therapies: A retrospective cohort study and systematic review of the literature","volume":"77","author":"Snast","year":"2017","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.det.2024.02.002_bib15","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1053\/j.gastro.2017.02.009","article-title":"Hepatitis B reactivation associated with immune suppressive and biological modifier therapies: current concepts, management strategies and future directions","volume":"152","author":"Loomba","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.det.2024.02.002_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.621247","article-title":"Biologics during pregnancy and breastfeeding among women with rheumatic diseases: safety clinical evidence on the road","volume":"12","author":"Beltagy","year":"2021","journal-title":"Front Pharmacol"},{"issue":"3","key":"10.1016\/j.det.2024.02.002_bib17","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.jaad.2019.04.042","article-title":"Joint american academy of dermatology\u2013national psoriasis foundation guidelines of care for the management and treatment of psoriasis with phototherapy","volume":"81","author":"Elmets","year":"2019","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.det.2024.02.002_bib18","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1001\/jamadermatol.2020.0218","article-title":"Evaluation for skin cancer and precancer in patients with vitiligo treated with long-term narrowband UV-B phototherapy","volume":"156","author":"Bae","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"1","key":"10.1016\/j.det.2024.02.002_bib19","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.det.2019.08.012","article-title":"Phototherapy in the pediatric population","volume":"38","author":"Juarez","year":"2020","journal-title":"Dermatol Clin"},{"issue":"4","key":"10.1016\/j.det.2024.02.002_bib20","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/bjd.12168","article-title":"Effect of narrowband ultraviolet B phototherapy on melanocytic naevi","volume":"168","author":"Lin","year":"2013","journal-title":"Br J Dermatol"},{"issue":"24","key":"10.1016\/j.det.2024.02.002_bib21","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1097\/CM9.0000000000001232","article-title":"Time to relapse after treatment withdrawal for different biologics used to treat plaque psoriasis","volume":"133","author":"Wang","year":"2020","journal-title":"Chin Med J (Engl)"},{"issue":"2","key":"10.1016\/j.det.2024.02.002_bib22","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1365-2133.1996.tb01155.x","article-title":"8-MOP PUVA for psoriasis: a comparison of a minimal phototoxic dose-based regimen with a skin-type approach","volume":"135","author":"Collins","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2024.02.002_bib23","doi-asserted-by":"crossref","DOI":"10.1111\/1346-8138.12541","article-title":"Remission period in psoriasis after multiple cycles of narrowband ultraviolet B phototherapy","author":"Ryu","year":"2014","journal-title":"J\u00a0Dermatol"},{"issue":"6","key":"10.1016\/j.det.2024.02.002_bib24","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1365-2133.1988.tb03489.x","article-title":"311 nm UVB phototherapy\u2014an effective treatment for psoriasis","volume":"119","author":"Green","year":"1988","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.det.2024.02.002_bib25","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1365-4632.2004.02398.x","article-title":"The effect of maintenance narrow-band ultraviolet B therapy on the duration of remission for psoriasis: a prospective randomized clinical trial","volume":"45","author":"Boztepe","year":"2006","journal-title":"Int J Dermatol"},{"issue":"8","key":"10.1016\/j.det.2024.02.002_bib26","doi-asserted-by":"crossref","DOI":"10.1080\/09546634.2018.1466022","article-title":"Comparison of the cost-effectiveness of biologic drugs used for moderate-to-severe psoriasis treatment in the United States","volume":"29","author":"Wu","year":"2018","journal-title":"J\u00a0Dermatol Treat"},{"key":"10.1016\/j.det.2024.02.002_bib27","doi-asserted-by":"crossref","DOI":"10.1111\/ijd.16677","article-title":"Systematic review and estimated cost-efficacy of biologics compared with narrowband ultraviolet B light for the treatment of moderate to severe psoriasis and atopic dermatitis","author":"McCoy","year":"2023","journal-title":"Int J Dermatol"},{"issue":"5","key":"10.1016\/j.det.2024.02.002_bib28","article-title":"Cost of prevalent psoriasis","volume":"70","year":"2014","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.det.2024.02.002_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2020.04.095","article-title":"Role of phototherapy in the era of biologics","volume":"84","author":"Torres","year":"2021","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.det.2024.02.002_bib30","doi-asserted-by":"crossref","DOI":"10.5070\/D3196018563","article-title":"Explicit and implicit copayments for phototherapy: Examining the cost of commuting","volume":"19","author":"Yentzer","year":"2013","journal-title":"Dermatol Online J"},{"issue":"7704","key":"10.1016\/j.det.2024.02.002_bib31","article-title":"Home versus outpatient ultraviolet B phototherapy for mild to severe psoriasis: pragmatic multicentre randomised controlled non-inferiority trial (PLUTO study)","volume":"338","author":"Koek","year":"2009","journal-title":"BMJ (Online)"},{"issue":"12","key":"10.1016\/j.det.2024.02.002_bib32","article-title":"Home narrowband ultraviolet b phototherapy for photoresponsive skin conditions: A health technology assessment","volume":"20","year":"2020","journal-title":"Ont Health Technol Assess Ser"},{"issue":"1","key":"10.1016\/j.det.2024.02.002_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2020.03.021","article-title":"Long-term use of home narrowband ultraviolet B phototherapy demonstrates high patient satisfaction, compliance, and low rates of adverse effects: A survey study","volume":"83","author":"Nguyen","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.det.2024.02.002_bib34","doi-asserted-by":"crossref","DOI":"10.1111\/phpp.12326","article-title":"A\u00a0cross-sectional, comparative study of home vs in-office NB-UVB phototherapy for vitiligo","volume":"33","author":"Dillon","year":"2017","journal-title":"Photodermatol Photoimmunol Photomed"},{"issue":"2","key":"10.1016\/j.det.2024.02.002_bib35","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3906\/sag-1810-110","article-title":"The efficacy and safety of targeted narrowband UVB therapy: a retrospective cohort study","volume":"49","author":"Esen Salman","year":"2019","journal-title":"Turk J Med Sci"},{"issue":"1","key":"10.1016\/j.det.2024.02.002_bib36","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10103-017-2360-1","article-title":"A\u00a0clinical review of phototherapy for psoriasis","volume":"33","author":"Zhang","year":"2018","journal-title":"Laser Med Sci"},{"key":"10.1016\/j.det.2024.02.002_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.696597","article-title":"Systematic review and recommendations to combine newer therapies with conventional therapy in psoriatic disease","volume":"8","author":"Arora","year":"2021","journal-title":"Front Med"},{"key":"10.1016\/j.det.2024.02.002_bib38","doi-asserted-by":"crossref","DOI":"10.2147\/PTT.S98952","article-title":"Combining biologic and phototherapy treatments for psoriasis: safety, efficacy, and patient acceptability","volume":"6","author":"Farahnik","year":"2016","journal-title":"Psoriasis Targets Ther"},{"issue":"6","key":"10.1016\/j.det.2024.02.002_bib39","doi-asserted-by":"crossref","DOI":"10.1111\/phpp.12134","article-title":"Recovery of the response to biological treatments using narrow band ultraviolet-B in patients with moderate to severe psoriasis: A retrospective study of 17 patients","volume":"30","author":"Belinch\u00f3n","year":"2014","journal-title":"Photodermatol Photoimmunol Photomed"}],"container-title":["Dermatologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863524000147?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863524000147?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T10:07:59Z","timestamp":1731578879000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733863524000147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S0733863524000147"],"URL":"https:\/\/doi.org\/10.1016\/j.det.2024.02.002","relation":{},"ISSN":["0733-8635"],"issn-type":[{"value":"0733-8635","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phototherapy for Psoriasis in the Age of Biologics","name":"articletitle","label":"Article Title"},{"value":"Dermatologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.det.2024.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}